These results support that EnaV’s activity is primarily determined by the presence of AXL expression but suggest that additional factors contribute to the response to EnaV downstream of AXL, e.g., the inherent sensitivity of the tumor cells to the payload as demonstrated in previous work [18]. The gene discussed is AXL; the disease is neoplasm.